Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam + alfentanil vs propofol for painless ultrasound gastroscopy biopsy
ChiCTR2400093020Phase 4Completed
- Sponsor
- Liaoning Province Cancer Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Pancreatic mass lesion comparing Propofol arm with Remimazolam + alfentanil arm (2 arms). Primary endpoint: Sedation success rate. Started Dec 2024; status: completed.
02
Drugs
remimazolamalfentanilpropofol
03
Conditions
Pancreatic mass lesion
Beyond the preview
Go deeper on ChiCTR2400093020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093020.